These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29732996)

  • 21. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
    Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
    Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis.
    Rub A; Shaker K; Kashif M; Arish M; Dukhyil AAB; Alshehri BM; Alaidarous MA; Banawas S; Amir K
    Protein Pept Lett; 2019; 26(5):371-376. PubMed ID: 30827222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Matadamas-Martínez F; Hernández-Campos A; Téllez-Valencia A; Vázquez-Raygoza A; Comparán-Alarcón S; Yépez-Mulia L; Castillo R
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31487860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
    Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
    Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular studies on trypanothione reductase, a target for antiparasitic drugs.
    Walsh C; Bradley M; Nadeau K
    Trends Biochem Sci; 1991 Aug; 16(8):305-9. PubMed ID: 1957352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New iminodibenzyl derivatives with anti-leishmanial activity.
    Arndt A; Liria CW; Yokoyama-Yasunaka JKU; Machini MT; Uliana SRB; Espósito BP
    J Inorg Biochem; 2017 Jul; 172():9-15. PubMed ID: 28414928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved inhibitors of trypanothione reductase by combination of motifs: synthesis, inhibitory potency, binding mode, and antiprotozoal activities.
    Eberle C; Lauber BS; Fankhauser D; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2011 Feb; 6(2):292-301. PubMed ID: 21275053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
    Venkatesan SK; Shukla AK; Dubey VK
    J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dataset generated for Dissection of mechanisms of Trypanothione Reductase and Tryparedoxin Peroxidase through dynamic network analysis and simulations in leishmaniasis.
    Kumar A; Saha B; Singh S
    Data Brief; 2017 Dec; 15():757-769. PubMed ID: 29159213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probing the structure of Leishmania major DHFR TS and structure based virtual screening of peptide library for the identification of anti-leishmanial leads.
    Rajasekaran R; Chen YP
    J Mol Model; 2012 Sep; 18(9):4089-100. PubMed ID: 22527276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis.
    Shukla AK; Patra S; Dubey VK
    Mol Cell Biochem; 2011 Jun; 352(1-2):261-70. PubMed ID: 21359528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania.
    Pandey RK; Verma P; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    Biomed Pharmacother; 2016 Oct; 83():141-152. PubMed ID: 27470561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening.
    Phan TN; Park KP; Benítez D; Comini MA; Shum D; No JH
    Biochem Biophys Res Commun; 2022 Dec; 637():308-313. PubMed ID: 36413853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from
    Maamri S; Benarous K; Yousfi M
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34206087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.
    Lee B; Bauer H; Melchers J; Ruppert T; Rattray L; Yardley V; Davioud-Charvet E; Krauth-Siegel RL
    J Med Chem; 2005 Nov; 48(23):7400-10. PubMed ID: 16279799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Silico Exploration of the Trypanothione Reductase (TryR) of
    Barrera-Téllez FJ; Prieto-Martínez FD; Hernández-Campos A; Martínez-Mayorga K; Castillo-Bocanegra R
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.
    Chan C; Yin H; McKie JH; Fairlamb AH; Douglas KT
    Amino Acids; 2002 Jun; 22(4):297-308. PubMed ID: 12107758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
    Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
    Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.